Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives

Multiple myeloma (MM) is a hematological neoplasm for which different chemotherapy treatments are used with several drugs in combination. One of the most frequently used drugs for the treatment of MM is the proteasome inhibitor bortezomib. Patients treated with bortezomib are at increased risk for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanz-Solas, Antonio, Labrador, Jorge, Alcaraz, Raquel, Cuevas, Beatriz, Vinuesa, Raquel, Cuevas, María Victoria, Saiz-Rodríguez, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145990/
https://www.ncbi.nlm.nih.gov/pubmed/37109081
http://dx.doi.org/10.3390/jpm13040695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145990/
https://www.ncbi.nlm.nih.gov/pubmed/37109081
http://dx.doi.org/10.3390/jpm13040695

Ejemplares similares